Robust and Transparent Silver Oxide Coating Fabricated at Room Temperature Kills Clostridioides difficile Spores, MRSA, and Pseudomonas aeruginosa

Antimicrobial coatings can inhibit the transmission of infectious diseases when they provide a quick kill that is achieved long after the coating application. Here, we describe the fabrication and testing of a glass coating containing Ag2O microparticles that was prepared from sodium silicate at room temperature. The half-lives of both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa on this coating are only 2-4 min. The half-life of Clostridioides difficile spores is about 9-12 min, which is extremely short for a spore. Additional tests on MRSA demonstrate that the coating retains its antimicrobial activity after abrasion and that an increased loading of Ag2O leads to a shorter half-life. This coating combines the properties of optical transparency, robustness, fast kill, and room temperature preparation that are highly desirable for an antimicrobial coating.

Simulations of transport regime in electrodeposition in different viscosity scenarios

In this work we study the effects of viscosity variations in thin-layer electrochemical deposition (ECD) under galvanostatic conditions through experimental measurements and theoretical modeling. The theoretical model, written in terms of dimensionless quantities, describes diffusive, migratory and convective ion transport in a fluid under galvanostatic conditions. Experiments reveal that as viscosity increases, convection decreases when the cell resistance remains constant. Our numerical model predicts that as viscosity increases, electroconvection becomes less relevant and concentration and convective fronts slow down. The time scaling of this phenomenon is studied and compared to previously reported low viscosity solution studies.

Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery

OBJECTIVE

Ketorolac tromethamine 0.5% and diclofenac sodium 0.1% ophthalmic solutions are approved for use by the U.S. Food and Drug Administration to avoid excessive postoperative inflammation after cataract surgery and implantation of an intraocular lens. This study compares the efficacy and toxicity of these nonsteroidal anti-inflammatory drugs for the first time.

DESIGN

Randomized, double-masked, prospective clinical trial.

PARTICIPANTS

A total of 120 patients assigned in equal numbers to 1 of the 2 treatment regimens.

INTERVENTION

Treatment with either ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions instilled four times daily for 30 days beginning the first postoperative day after surgery.

MAIN OUTCOME MEASURES

Objective (Kowa FC 1000 laser cell and flare meter) and subjective (slit-lamp biomicroscope) measurements of inflammation and toxicity were made and compared at three separate post-operative visits.

RESULTS

The anti-inflammatory effects of the two treatment regimens were not statistically different at any of the postoperative visits. Patients tolerated both treatments equally well.

CONCLUSIONS

This study shows diclofenac sodium 0.1% and ketorolac tromethamine 0.5% ophthalmic solutions are equally effective and safe for the control of postoperative inflammation after uncomplicated cataract surgery performed by phacoemulsification followed by the implantation of a foldable intraocular lens.

The complete sequence of a 15,820 bp segment of Saccharomyces cerevisiae chromosome XI contains the UBI2 and MPL1 genes and three new open reading frames

As part of the EEC yeast genome program, a fragment of 15,820 bp from the right arm of Saccharomyces cerevisiae chromosome XI has been sequenced. This fragment corresponds roughly to the centromere-distal half of cosmid pUKG046 and to a small fragment of cosmid pUKG096, which are located approximately 150 kb from the centromere. It contains four open reading frames (ORFs) which encode potential proteins of more than 100 amino acid residues, as well as the UBI2 gene which carries an intron and does not show up as an ORF in the sequence analysis programs. One of the putative proteins, YKR412, is very rich in serine and has significant homology at the carboxyl end to Nopp140 phosphoprotein. YKR413 has several predicted transmembrane domains. YKR15, which has been recently cloned as the MPL1 gene, encodes a polypeptide that shows homologies to myosin heavy chain and to the cytoskeleton protein Uso1.

Cyclic AMP mediated gene expression in bovine corneal endothelial cells

PURPOSE

Agents that increase intracellular levels of cAMP mediate gene expression associated with cellular morphology, growth, and/or differentiation via the cAMP response element (CRE). The cAMP element binding protein (CREB) is a transcriptional activator that binds and stimulates gene expression from the CRE in the promoters of cAMP responsive genes. This study was designed to characterize the cyclic AMP (cAMP) transcription apparatus in bovine corneal endothelial cells (BCE).

METHODS

CRE transcriptional activity was determined by transient transfection assays using the CRE-chloramphenicol acetyl transferase gene (CRE-CAT) fusion reporter construct. Western blot analyses were performed to determine whether CREB was present in BCE. Mobility shift DNA-binding assay using gel electrophoresis and DNase I protection assays were performed to exclude the possibility of other CRE-binding factors.

RESULTS

The authors identified the transcription factor, CREB, in nuclear extracts from BCE by Western blot analysis and showed that its DNA-binding characteristics are identical to the previously characterized CREB protein by DNase I protection and mobility shift DNA-binding studies. Transient transfection studies using the CRE-CAT reporter constructs revealed that the beta-adrenergic receptor agonist, isoproterenol, stimulates gene expression to levels similar to those induced by forskolin, a direct activator of adenylate cyclase (6.0- and 7.2-fold, respectively).

CONCLUSIONS

The results suggest that agents that modulate receptors coupled to adenylate cyclase may effect the corneal endothelium by altering gene expression through the second messenger, cAMP.

Characterization of motifs which are critical for activity of the cyclic AMP-responsive transcription factor CREB

Cyclic AMP mediates the hormonal stimulation of a number of eukaryotic genes by directing the protein kinase A (PK-A)-dependent phosphorylation of transcription factor CREB. We have previously determined that although phosphorylation at Ser-133 is critical for induction, this site does not appear to participate directly in transactivation. To test the hypothesis that CREB ultimately activates transcription through domains that are distinct from the PK-A site, we constructed a series of CREB mutants and evaluated them by transient assays in F9 teratocarcinoma cells. Remarkably, a glutamine-rich region near the N terminus appeared to be important for PK-A-mediated induction of CREB since removal of this domain caused a marked reduction in CREB activity. A second region consisting of a short acidic motif (DLSSD) C terminal to the PK-A site also appeared to synergize with the phosphorylation motif to permit transcriptional activation. Biochemical experiments with purified recombinant CREB protein further demonstrate that the transactivation domain is more sensitive to trypsin digestion than are the DNA-binding and dimerization domains, suggesting that the activator region may be structured to permit interactions with other proteins in the RNA polymerase II complex.

Characteristics of the cAMP response unit

Cyclic AMP (cAMP) mediates the hormonal stimulation of numerous cellular processes by regulating the phosphorylation of critical target proteins. In this report, we review current work suggesting that cAMP regulates transcription of eukaryotic genes through the reversible phosphorylation of a target nuclear protein called CREB. As CREB is currently the only transcription factor that is regulated by a well-defined cytoplasmic kinase-kinase-A, these studies may help to elucidate the general mechanisms underlying signal transduction.

Regulation of cAMP-inducible genes by CREB

A large number of neuropeptides and neurotransmitters stimulate neuronal cells through the second messenger cAMP. These synaptic signals often cause profound changes in neuronal function by altering basic patterns of gene expression. Cyclic AMP, in turn, regulates a number of these genes through a conserved cAMP response element (CRE). Recently, a nuclear CRE-binding protein, CREB, has been shown to bind to the CRE and stimulate the transcription of cAMP-responsive genes. This article reviews recent progress towards understanding the mechanism by which cAMP modulates the activity of CREB to stimulate gene transcription.

Characterization of a bipartite activator domain in transcription factor CREB

In this paper, we characterize a trans-activating region in CREB, termed alpha, that interacts cooperatively with the kinase A phosphorylation motif to stimulate transcription. The alpha region appears to be encoded by an alternate exon that is deleted in a CREB-related cDNA named delta CREB. Both proteins are expressed in eukaryotic cells, although the activity of CREB is 10-fold higher than that of delta CREB. Circular dichroism data on a synthetic "alpha peptide" combined with results from in vitro mutagenesis experiments support the hypothesis that the alpha region contains an amphipathic alpha helix whose structure is critical to CREB activity. We propose that phosphorylation by kinase A may stimulate CREB activity in part by modulating the structure of alpha and thus may stimulate its ability to interact with other proteins in the polymerase II complex.

Lethal cyclosporine associated toxicity in the rabbit: similar findings in two distant and independent transplant laboratories

A collaborative study was initiated between Basel and Irvine Laboratories named above in an attempt to characterize a unique and lethal gastrointestinal toxicity in rabbits associated with cyclosporine administration. Data from both laboratories were combined and analyzed. The rate of weight loss in CsA treated rabbits was found to be a significant linear function of the dose. In addition, animal survival decreased and showed a dose-dependent linear relationship to CsA use. Grossly, all of the animals presented with full stomachs, incompletely digested, dry, hard, rabbit chow. Histopathology could not provide any insight into the mechanisms of this gross finding and remain unclear. The complete similarity of clinical and histopathological results in distant independent laboratories confirms the specificity of this CsA associated toxicity in the rabbit.

Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133

In this paper, we demonstrate that phosphorylation of CREB at Ser-133 is induced 6-fold in vivo, following treatment of PC12 cells with forskolin. By contrast, no such induction was observed in the kinase A-deficient PC12 line A126-1B2 (A126). Using F9 teratocarcinoma cells, which are unresponsive to cAMP, we initiated a series of transient expression experiments to establish a causal link between phosphorylation of CREB and trans-activation of cAMP-responsive genes. Inactivating the kinase A phosphorylation site by in vitro mutagenesis of the cloned CREB cDNA at Ser-133 completely abolished CREB transcriptional activity. As CREB mutants containing acidic residues in place of the Ser-133 phosphoacceptor were also transcriptionally inactive, these results suggest that phosphorylation of CREB may stimulate transcription by a mechanism other than by simply providing negative charge.

A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence

Cyclic AMP regulates the expression of a number of genes through a conserved promoter element, the CRE1. Moreover, transcriptional induction by cAMP requires the activation of cAMP-dependent protein kinase (protein kinase A). We have previously characterized the cAMP response element binding protein (CREB) in PC12 cells and brain tissue as a nuclear factor, of relative molecular mass 43,000, whose transcriptional efficacy is regulated by protein kinase A phosphorylation. CREB stimulates transcription on binding to the CRE as a dimer. Experiments suggesting that the dimerization and transcriptional efficacy of CREB are each stimulated by phosphorylation at distinct sites prompted us to suggest that CREB is regulated by multiple kinases in vivo. We now report the isolation of a cDNA clone for rat CREB using amino-acid sequence information from purified CREB protein. Sequence analysis of this CREB cDNA predicts a cluster of protein kinase A, protein kinase C and casein kinase II consensus recognition sites near the N terminus of the protein. The proximity of these potential phosphorylation sites to one another indicates that they may interact either positively or negatively to regulate CREB bioactivity.

Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB

A nuclear protein, CREB, has been isolated from rat brain and shown to stimulate transcription of the cyclic AMP-responsive gene somatostatin as a dimer. Biochemical analysis suggests that dimerization and transcriptional efficacy of CREB protein in vitro are regulated by phosphorylation. These findings demonstrate that cellular signals can modulate gene expression by regulating the covalent modification of pre-existing nuclear factors.

Decreased reactivity of allosera against target lymphocytes obtained following thermal injury or long-term cyclosporine treatment

We speculated that two diverse causes of potent cell-mediated immune suppression, cyclosporine (CsA) and thermal trauma, may demonstrate some similar actions, and thus tested whether either could alter antisera reactivity against allogeneic target lymphocytes. Target splenocytes from 40% body surface area full-thickness burned Brown-Norway (BN) rats demonstrated significant (P = 0.004) decreased reactivity (agglutination) with antisera produced across a full allogeneic barrier (RT1 major histocompatibility complex (MHC) and non-MHC) compared to control splenocytes. Depression of allogeneic splenic target cell reactivity against Lewis (LEW)-anti-BN allosera was similarly observed using lymphocytes from long-term CsA-treated rats (P = 0.004). The decreased reactivity induced by burn trauma was transferable to pooled normal splenocytes or blood lymphocytes by preincubation with burn plasma (P less than 0.001), and was confirmed by a cellular enzyme-linked immunosorbent assay (CELISA) (P = 0.003). In summary, a similarity consisting of decreased antibody reactivity against lymphocytes from either burned or long-term CsA-treated animals was demonstrated. These results suggested that lymphocyte cell surface allogeneic determinants and their expression and/or availability were altered by either regimen.

FiltraCheck-UTI, a rapid, disposable system for detection of bacteriuria

The initial evaluation of the FiltraCheck-UTI bacteriuria detection system is described. The colorimetric test, which utilizes a disposable filter disk and a stable reagent system, does not require instrumentation. The test procedure is simple and may be performed in less than 1 min. Results obtained with the FiltraCheck-UTI system were compared with those obtained by conventional semiquantitative culturing. Of 1,198 urine specimens evaluated, 202 (16.9%) were determined to be significant positives at greater than or equal to 10(5) CFU/ml by the culture method. The sensitivity and specificity of the FiltraCheck-UTI system were 96.5 and 79.7%, respectively, and the negative predictive value was 99.1%. The high sensitivity, rapidity, simplicity, and unique disposable format of the FiltraCheck-UTI system offer significant advantages over other commonly used screening methods.

Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors

Eight LEW rat recipients possessing long-term-surviving (206-701 days) LBN vascularized hind limb allografts (CTAs) were tested for donor-host lymphoid chimerism. The recipients received various cyclosporine (CsA) treatment protocols in order to induce indefinite CTA acceptance. Histological examination of long-term-surviving CTAs demonstrated normal-appearing bone marrow in the donor limb. Lymphocytes isolated from host hemopoietic tissues (peripheral blood and/or spleen) by ficoll-hypaque density gradient centrifugation were tested against LEW-anti-BN antisera. Comparisons were made to standard curves employing various known concentrations of LBN and LEW cell combinations. The level of lymphocyte agglutination (dependent variable) showed a significant (P less than 0.025-0.005) linear relationship to the concentration of LBN donor cells (independent variable) present. Lymphocyte suspensions isolated from long-term CTA host peripheral blood and/or spleen showed a mean of 19.7% (+/- 9.7-95% confidence interval) donor LBN mononuclear cells present. Thus, it appeared that lymphoid cells originated from, and/or were released from LBN donor bone marrow into the circulation, resulting in chimeric repopulation of hemopoietic tissues. The presence of donor immunocytes in these limb allograft recipients may have been beneficial, and thus could have helped contribute to the long-term CTA survival observed.